Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now later-stage tilt small index

DFU: later-stage trial registry

5 of 5 indexed DFU trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 5 currently recruiting · #3,391 of 28,707 conditions by registered trial count

DFU: 5 US clinical trials tracked, 5 recruiting.

DFU is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is BioLab Holdings, running 2 of these trials.

Enrollment posture brief

Registry condition dfu

OPEN 5 | RECR 100% | LATE 4 | EARLY 0 | RANK #3391 | SPON 2

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

DFU (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near DFU

DFU lists 5 open slots (100% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for DFU on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. DFU is recruiting above its size-band peers.

    5 of 5 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates DFU research.

    BioLab Holdings accounts for 2 of 5 trials (40%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical DFU enrolment sits around 124 participants.

    Median target enrolment is 124 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. DFU research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 44

Phase Distribution

PhaseTrial count
Phase 4 4

Top Sponsors

Named interventions

Most-linked intervention names on DFU records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Membrane Wrap-Hydro™ DFU Other
2 trials
Membrane Wrap-Lite™ DFU Other
2 trials
Membrane Wrap™ DFU Other
2 trials
Tri-Membrane Wrap™ DFU Other
2 trials
Tri-Membrane Wrap™ VLU Other
1 trials
Slam + SOC Other
1 trials
Standard of Care DFU Other
1 trials
XWRAP Other
1 trials

US sites by state

Facility locations filed on DFU trials. A trial with sites in several states counts in each.

Pennsylvania 3 trials
Michigan 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this DFU page

5 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This DFU condition card totals 5 registered trials; most-linked intervention Membrane Wrap-Hydro™ DFU; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.